Validation of the GenoType® MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam

[1]  F. Cobelens,et al.  The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  R. Jou,et al.  Performance Assessment of the GenoType MTBDRplus Test and DNA Sequencing in Detection of Multidrug-Resistant Mycobacterium tuberculosis , 2009, Journal of Clinical Microbiology.

[3]  K. Kam,et al.  Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance , 2009, The Lancet.

[4]  M. Joloba,et al.  Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis , 2009, BMC infectious diseases.

[5]  Nalin Rastogi,et al.  Evaluation of Methods for Rapid Detection of Resistance to Isoniazid and Rifampin in Mycobacterium tuberculosis Isolates Collected in the Caribbean , 2008, Journal of Clinical Microbiology.

[6]  V. Thomsen,et al.  Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  R. O'brien,et al.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. , 2008, American journal of respiratory and critical care medicine.

[8]  S. Rüsch-Gerdes,et al.  Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens , 2007, Journal of Clinical Microbiology.

[9]  F. Cobelens,et al.  Antituberculosis drug resistance in the south of Vietnam: prevalence and trends. , 2006, The Journal of infectious diseases.

[10]  V. Jarlier,et al.  Performance of the Genotype MTBDR Line Probe Assay for Detection of Resistance to Rifampin and Isoniazid in Strains of Mycobacterium tuberculosis with Low- and High-Level Resistance , 2006, Journal of Clinical Microbiology.

[11]  D. van Soolingen,et al.  Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  D. Cirillo,et al.  Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in Italy , 2006, Journal of Clinical Microbiology.

[13]  C. Çavuşoğlu,et al.  Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolates , 2006, Journal of Clinical Microbiology.

[14]  F. Cobelens,et al.  Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  H. Soini,et al.  Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosis , 2006, Journal of Clinical Microbiology.

[16]  Leen Rigouts,et al.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology , 2006, BMC Microbiology.

[17]  S. Niemann,et al.  Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  M. Weizenegger,et al.  Use of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates , 2005, Journal of Clinical Microbiology.

[19]  Stefan Niemann,et al.  Definition of the Beijing/W Lineage of Mycobacterium tuberculosis on the Basis of Genetic Markers , 2004, Journal of Clinical Microbiology.

[20]  D. van Soolingen,et al.  Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  Bruce Budowle,et al.  Evaluation of a multicapillary electrophoresis instrument for mitochondrial DNA typing. , 2003, Journal of forensic sciences.

[22]  Annelies Van Rie,et al.  Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence Community , 2001, Journal of Clinical Microbiology.

[23]  D. van Soolingen,et al.  Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. , 2000, Emerging infectious diseases.

[24]  David A. Mead,et al.  Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid , 1998 .

[25]  K. Kremer,et al.  Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. , 1998, Methods in molecular biology.

[26]  D. Mead,et al.  Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. , 1998, Science.

[27]  D. Mitchison.  How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  J. Musser,et al.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  D. Rouse,et al.  Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis , 1997, Antimicrobial agents and chemotherapy.

[30]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[31]  D van Soolingen,et al.  Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.

[32]  W. Jacobs,et al.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.

[33]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[34]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[35]  J. Grosset,et al.  [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation]. , 1963, Revue de tuberculose et de pneumologie.